257 related articles for article (PubMed ID: 21719110)
1. The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: an open label trial.
Berk M; Dean O; Cotton SM; Gama CS; Kapczinski F; Fernandes BS; Kohlmann K; Jeavons S; Hewitt K; Allwang C; Cobb H; Bush AI; Schapkaitz I; Dodd S; Malhi GS
J Affect Disord; 2011 Dec; 135(1-3):389-94. PubMed ID: 21719110
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of adjunctive N-acetylcysteine in acute bipolar depression: A randomized placebo-controlled study.
Ellegaard PK; Licht RW; Nielsen RE; Dean OM; Berk M; Poulsen HE; Mohebbi M; Nielsen CT
J Affect Disord; 2019 Feb; 245():1043-1051. PubMed ID: 30699846
[TBL] [Abstract][Full Text] [Related]
3. N-acetyl cysteine for depressive symptoms in bipolar disorder--a double-blind randomized placebo-controlled trial.
Berk M; Copolov DL; Dean O; Lu K; Jeavons S; Schapkaitz I; Anderson-Hunt M; Bush AI
Biol Psychiatry; 2008 Sep; 64(6):468-75. PubMed ID: 18534556
[TBL] [Abstract][Full Text] [Related]
4. N-acetylcysteine as an adjunctive treatment for bipolar depression and major depressive disorder: a systematic review and meta-analysis of double-blind, randomized placebo-controlled trials.
Kishi T; Miyake N; Okuya M; Sakuma K; Iwata N
Psychopharmacology (Berl); 2020 Nov; 237(11):3481-3487. PubMed ID: 32767039
[TBL] [Abstract][Full Text] [Related]
5. A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo.
Berk M; Turner A; Malhi GS; Ng CH; Cotton SM; Dodd S; Samuni Y; Tanious M; McAulay C; Dowling N; Sarris J; Owen L; Waterdrinker A; Smith D; Dean OM
BMC Med; 2019 Jan; 17(1):18. PubMed ID: 30678686
[TBL] [Abstract][Full Text] [Related]
6. Maintenance N-acetyl cysteine treatment for bipolar disorder: a double-blind randomized placebo controlled trial.
Berk M; Dean OM; Cotton SM; Gama CS; Kapczinski F; Fernandes B; Kohlmann K; Jeavons S; Hewitt K; Moss K; Allwang C; Schapkaitz I; Cobb H; Bush AI; Dodd S; Malhi GS
BMC Med; 2012 Aug; 10():91. PubMed ID: 22891797
[TBL] [Abstract][Full Text] [Related]
7. A Double-Blind, Randomized, Placebo-Controlled Study of Aspirin and N-Acetylcysteine as Adjunctive Treatments for Bipolar Depression.
Bauer IE; Green C; Colpo GD; Teixeira AL; Selvaraj S; Durkin K; Zunta-Soares GB; Soares JC
J Clin Psychiatry; 2018 Dec; 80(1):. PubMed ID: 30549489
[TBL] [Abstract][Full Text] [Related]
8. Design and rationale of a 16-week adjunctive randomized placebo-controlled trial of mitochondrial agents for the treatment of bipolar depression.
Dean OM; Turner A; Malhi GS; Ng C; Cotton SM; Dodd S; Sarris J; Samuni Y; Tanious M; Dowling N; Waterdrinker A; Smith D; Berk M
Braz J Psychiatry; 2015; 37(1):3-12. PubMed ID: 25295681
[TBL] [Abstract][Full Text] [Related]
9. N-acetylcysteine for major depressive episodes in bipolar disorder.
Magalhães PV; Dean OM; Bush AI; Copolov DL; Malhi GS; Kohlmann K; Jeavons S; Schapkaitz I; Anderson-Hunt M; Berk M
Braz J Psychiatry; 2011 Dec; 33(4):374-8. PubMed ID: 22189927
[TBL] [Abstract][Full Text] [Related]
10. A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I).
Young AH; McElroy SL; Bauer M; Philips N; Chang W; Olausson B; Paulsson B; Brecher M;
J Clin Psychiatry; 2010 Feb; 71(2):150-62. PubMed ID: 20122369
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of adjunctive N-acetylcysteine in major depressive disorder: a double-blind, randomized, placebo-controlled trial.
Berk M; Dean OM; Cotton SM; Jeavons S; Tanious M; Kohlmann K; Hewitt K; Moss K; Allwang C; Schapkaitz I; Robbins J; Cobb H; Ng F; Dodd S; Bush AI; Malhi GS
J Clin Psychiatry; 2014 Jun; 75(6):628-36. PubMed ID: 25004186
[TBL] [Abstract][Full Text] [Related]
12. A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II).
McElroy SL; Weisler RH; Chang W; Olausson B; Paulsson B; Brecher M; Agambaram V; Merideth C; Nordenhem A; Young AH;
J Clin Psychiatry; 2010 Feb; 71(2):163-74. PubMed ID: 20122366
[TBL] [Abstract][Full Text] [Related]
13. Topiramate for acute affective episodes in bipolar disorder.
Vasudev K; Macritchie K; Geddes J; Watson S; Young A
Cochrane Database Syst Rev; 2006 Jan; (1):CD003384. PubMed ID: 16437453
[TBL] [Abstract][Full Text] [Related]
14. Adjunctive Maintenance Lamotrigine for Pediatric Bipolar I Disorder: A Placebo-Controlled, Randomized Withdrawal Study.
Findling RL; Chang K; Robb A; Foster VJ; Horrigan J; Krishen A; Wamil A; Kraus JE; DelBello M
J Am Acad Child Adolesc Psychiatry; 2015 Dec; 54(12):1020-1031.e3. PubMed ID: 26598477
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-6 and total antioxidant capacity levels following
Bortolasci CC; Voigt C; Turner A; Mohebbi M; Gray L; Dodd S; Walder K; Berk M; Cotton SM; Malhi GS; Ng CH; Dowling N; Sarris J; Dean OM
Acta Neuropsychiatr; 2020 Dec; 32(6):313-320. PubMed ID: 32600481
[TBL] [Abstract][Full Text] [Related]
16. Novel Augmentation Strategies in Major Depression.
Martiny K
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
[TBL] [Abstract][Full Text] [Related]
17. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
Houston JP; Tohen M; Degenhardt EK; Jamal HH; Liu LL; Ketter TA
J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
[TBL] [Abstract][Full Text] [Related]
18. Effects of venlafaxine versus lithium monotherapy on quality of life in bipolar II major depressive disorder: Findings from a double-blind randomized controlled trial.
Lorenzo-Luaces L; Amsterdam JD
Psychiatry Res; 2018 Jan; 259():455-459. PubMed ID: 29136600
[TBL] [Abstract][Full Text] [Related]
19. N-Acetylcysteine for Nonsuicidal Self-Injurious Behavior in Adolescents: An Open-Label Pilot Study.
Cullen KR; Klimes-Dougan B; Westlund Schreiner M; Carstedt P; Marka N; Nelson K; Miller MJ; Reigstad K; Westervelt A; Gunlicks-Stoessel M; Eberly LE
J Child Adolesc Psychopharmacol; 2018 Mar; 28(2):136-144. PubMed ID: 29053023
[TBL] [Abstract][Full Text] [Related]
20. Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study.
Vieta E; Owen R; Baudelet C; McQuade RD; Sanchez R; Marcus RN
Curr Med Res Opin; 2010 Jun; 26(6):1485-96. PubMed ID: 20429835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]